Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.

We have recently reported that the fluoroquinolone antibacterial DW-116 induces a significant developmental toxicity in rat. The present study was conducted to better understand the teratogenic effects of DW-116 at several developmental toxic doses in rats. DW-116 was orally administered to pregnant rats from gestational day (GD) 6 through 16 at dose levels of 0, 320, 400, and 500 mg/kg/day. All dams were subjected to caesarean section on GD 20 and their fetuses were examined for external, visceral, and skeletal abnormalities. At above 400 mg/kg, severe decreases in maternal body weight gain, food consumption, litter size, fetal weight and placental weight, and severe increases in resorption rate and fetal morphological alterations were observed. At 320 mg/kg, mild decreases in maternal body weight gain, food consumption, fetal weight and placental weight, and mild increases in fetal variations and retardations were observed. These results suggest that DW-116 is embryotoxic at above 320 mg/kg/day and is embryolethal and teratogenic at above 400 mg/kg in pregnant rats and that DW-116 is a selective developmental toxicant in rat conceptuses.

[1]  M. Chung,et al.  Developmental toxicity of flupyrazofos, a new organophosphorus insecticide, in rats. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  Ho-Chul Shin,et al.  Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. , 2001, Life sciences.

[3]  R. Lochmiller,et al.  Evaluation Of Myelotoxicity In Cotton Rats (Sigmodon hispidus) Exposed To Environmental Contaminants. I. In Vitro Bone-Marrow Progenitor Culture , 2001, Journal of toxicology and environmental health. Part A.

[4]  Ho-Chul Shin,et al.  Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats , 2000, Archives of Toxicology.

[5]  T. Gootz,et al.  Chemistry and Mechanism of Action of the Quinolone Antibacterials , 2000 .

[6]  I. Chahoud,et al.  Correlation between maternal toxicity and embryo/fetal effects. , 1999, Reproductive toxicology.

[7]  K. Imai,et al.  Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration. , 1999, Teratogenesis, carcinogenesis, and mutagenesis (Print).

[8]  C. Meyerhoff,et al.  Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects. , 1998, The Journal of antimicrobial chemotherapy.

[9]  J. C. Kim,et al.  Embryotoxic effects of SKI 2053R, a new potential anticancer agent, in rats. , 1998, Reproductive toxicology.

[10]  T. Inagaki,et al.  The cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma in Vitro , 1997, Cancer.

[11]  C. Mitoma,et al.  Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[12]  C. Shim,et al.  Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats. , 1997, Journal of pharmaceutical sciences.

[13]  R. G. York,et al.  Terminology of developmental abnormalities in common laboratory mammals (version 1). , 1997, Teratology.

[14]  E. Choi,et al.  In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. , 1997, The Journal of antimicrobial chemotherapy.

[15]  Y. Shindo,et al.  [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration] , 1996 .

[16]  M. Hirohashi,et al.  Toxicity of quinolone antimicrobial agents. , 1995, Journal of toxicology and environmental health.

[17]  V. Tullio,et al.  Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results. , 1994, The Journal of antimicrobial chemotherapy.

[18]  H. Neu,et al.  Quinolone antimicrobial agents. , 1992, Annual review of medicine.

[19]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.

[20]  R. Kavlock,et al.  An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessments. , 1989, Toxicology.

[21]  K. Khera Maternal toxicity in humans and animals: effects on fetal development and criteria for detection. , 1987, Teratogenesis, carcinogenesis, and mutagenesis.

[22]  C. Kimmel,et al.  Skeletal deviations in rats: malformations or variations? , 1973, Teratology.

[23]  J. Wilson Methods for administering agents and detecting malformations in experimental animals , 1965 .

[24]  A. B. Dawson A Note on the Staining of the Skeleton of Cleared Specimens with Alizarin Red S , 1926 .